BioLife Solutions Inc (BLFS)
Debt-to-equity ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 18,311 | 20,937 | 23,572 | 23,692 | 23,793 | 24,207 | 6,188 | 6,313 | 6,353 | 6,122 | 5,019 | 916 | 655 | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 337,663 | 332,017 | 352,128 | 358,107 | 364,188 | 405,120 | 409,544 | 476,075 | 478,047 | 489,259 | 452,281 | 208,777 | 204,429 | 186,851 | 105,843 | 67,709 | 43,321 | 35,191 | 2,072 | -3,740 |
| Debt-to-equity ratio | 0.05 | 0.06 | 0.07 | 0.07 | 0.07 | 0.06 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $18,311K ÷ $337,663K
= 0.05
BioLife Solutions Inc's debt-to-equity ratio has been relatively stable over the quarters, with values ranging from 0.05 to 0.07. This indicates that the company has a conservative capital structure, with a lower reliance on debt financing compared to equity. The decreasing trend in the debt-to-equity ratio over the quarters suggests that the company is gradually reducing its debt levels relative to equity, which can be viewed positively as it signifies improved financial stability and lower financial risk. The debt-to-equity ratio reaching 0.00 in recent quarters indicates that the company might be debt-free or carrying a minimal amount of debt in relation to its equity, reflecting a strong financial position in the short term.
Peer comparison
Dec 31, 2023